(Total Views: 512)
Posted On: 06/22/2020 2:02:36 PM
Post# of 36568
According to the GNBTP S-1 they are in advanced "touch" with someone...
Page 52 GNBTP S-1:
The funding for the development of a vaccine of SARS-CoV-2 virus is in advanced discussions and currently expected that the development costs will be borne by the U.S. and foreign government agencies and without additional external funding, Generex will not pursue these projects.
https://www.sec.gov/Archives/edgar/data/10597...forms1.htm
Page 52 GNBTP S-1:
The funding for the development of a vaccine of SARS-CoV-2 virus is in advanced discussions and currently expected that the development costs will be borne by the U.S. and foreign government agencies and without additional external funding, Generex will not pursue these projects.
https://www.sec.gov/Archives/edgar/data/10597...forms1.htm
(2)
(0)
